Diabetes drug may cause heart attack

If the patient suffers from a heart disease and is taking rosiglitazone, then there are chances of the drug user intensifying the risk of a heart attack or a heart failure.

“The New York Times” has cited a confidential US government report that recommended the removal of the rosiglitazone drug from the market. Hundreds of people taking the drug needlessly risk heart attacks and heart failure, according to the report.

Rosiglitazone is an anti-diabetes drug in the thiazolidinedione class. In India, it is sold under the brand name Windia.